Age-related macular degeneration and antioxidant vitamins: recent findings

Curr Opin Clin Nutr Metab Care. 2010 Jan;13(1):28-33. doi: 10.1097/MCO.0b013e32833308ff.

Abstract

Purpose of review: The purpose of the present review is to evaluate the most recent evidence for a role of antioxidant nutrients in the prevention or delay in progression of age-related macular degeneration (AMD), a major cause of visual impairment and blindness in the aging population.

Recent findings: Recent human studies (>2008) report a decreased AMD risk with increased intakes of lutein/zeaxanthin, B vitamins, zinc and docosahexaenoic acid but an increased risk with increased intakes of beta-carotene and vitamin E. These latter findings are inconsistent with previous reports (<2008).

Summary: Findings on the association of certain antioxidants and docosahexaenoic acid support a role for nutrition in a decreased risk of AMD. The inconsistent findings of an increased risk with increased intake of beta-carotene and vitamin E warrants continued investigation into these relationships.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Antioxidants / therapeutic use*
  • Carotenoids / adverse effects
  • Carotenoids / therapeutic use
  • Docosahexaenoic Acids / therapeutic use
  • Humans
  • Macular Degeneration / prevention & control*
  • Micronutrients / therapeutic use*
  • Risk Factors
  • Vitamin E / adverse effects
  • Vitamin E / therapeutic use

Substances

  • Antioxidants
  • Micronutrients
  • Vitamin E
  • Docosahexaenoic Acids
  • Carotenoids